Introduction: P2 Receptors

$63.00 plus tax (Refund Policy)

Buy Article:


The current status of ligand gated ion channel P2X and G protein-coupled P2Y receptor subtypes is described. This is followed by a summary of what is known of the distribution and roles of these receptor subtypes. Potential therapeutic targets of purinoceptors are considered, including those involved in cardiovascular, nervous, respiratory, urinogenital, gastrointestinal, musculo-skeletal and special sensory diseases, as well as inflammation, cancer and diabetes. Lastly, there are some speculations about future developments in the purinergic signalling field.

Keywords: g protein-coupled p2y receptor; ligand gated ion channel; p2 receptors; purinergic signalling; purinoceptors

Document Type: Review Article


Affiliations: Autonomic Neuroscience Institute, Royal Free and University College, Rowland Hill Street, London NW3 2PF, U.K..

Publication date: April 1, 2004

Related content



Share Content

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more